GL1X · GenesisL1 explorer

UniProt P17301

P17301

P17301 (UniProt P17301): 24 experimental structures and 1 predicted model on GenesisL1, 14 ligands bound. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
P17301
Experimental structures
24
Predicted models
1
Ligands
14

Structures

25 records of P17301 in the MolNFT archive: 24 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1AOXI domain from integrin ALPHA2-BETA1x-ray diffractionA, B——
1AOXI domain from integrin ALPHA2-BETA1x-ray diffractionA, B——
1DZIintegrin alpha2 I domain / collagen complexx-ray diffractionA——
1DZIIntegrin ALPHA2 I domain / collagen complexx-ray diffractionA——
1V7PStructure of EMS16-alpha2-I domain complexx-ray diffractionC——
1V7PStructure of EMS16-ALPHA2-I domain complexx-ray diffractionC——
4BJ3Integrin alpha2 I domain E318W-collagen complexx-ray diffractionA, B——
4BJ3Integrin ALPHA2 I domain E318W-collagen complexx-ray diffractionA, B——
5HJ2Integrin alpha2beta1 I-domainx-ray diffractionC, A, B, D, E, FCA, CL, SO4—
5HJ2Integrin ALPHA2BETA1 I-domainx-ray diffractionC, A, B, D, E, F——
5THPRhodocetin in complex with the integrin ALPHA2-a domainx-ray diffractionC, F, I, L, O, RCL, NA, MG, SO4—
6ND8Rhodocetin in complex with the integrin ALPHA2-a domain and bariumx-ray diffractionC, F, I, L, O, RSO4, BA, NA, CL—
6ND8Rhodocetin in complex with the integrin ALPHA2-a domain and bariumx-ray diffractionC, F, I, L, O, RSO4, BA, NA, CL—
6ND9Rhodocetin in complex with the integrin ALPHA2-a domain with calciumx-ray diffractionC, F, I, L, O, RSO4, CA, NA, CL—
6ND9Rhodocetin in complex with the integrin ALPHA2-a domain with calciumx-ray diffractionC, F, I, L, O, RSO4, CA, NA, CL—
6NDARhodocetin in complex with the integrin ALPHA2-a domain and cadmiumx-ray diffractionC, F, I, L, O, RCD, SO4, NA, CL—
6NDBRhodocetin in complex with the integrin ALPHA2-a domain and cobaltx-ray diffractionC, F, I, L, O, RSO4, CO, NA, CL—
6NDCRhodocetin in complex with the integrin ALPHA2-a domain with chromium boundx-ray diffractionC, F, I, L, O, RCR, SO4, NA, CL—
6NDDRhodocetin in complex with the integrin ALPHA2-a domain with manganese boundx-ray diffractionC, F, I, L, O, RMN, SO4, NA, CL—
6NDERhodocetin in complex with the integrin ALPHA2-a domain with prasedymiumx-ray diffractionC, F, I, L, O, RSO4, PR, NA, CL—
6NDFRhodocetin in complex with the integrin ALPHA2-a domain with strontiumx-ray diffractionC, F, I, L, O, RSO4, SR, NA, CL—
6NDGRhodocetin in complex with the integrin ALPHA2-a domain with yttrium boundx-ray diffractionC, F, I, L, O, RSO4, Y1, NA, CL—
6NDHRhodocetin in complex with the integrin ALPHA2-a domain and zincx-ray diffractionC, F, I, L, O, RSO4, ZN, NA, CL—
6NDHRhodocetin in complex with the integrin ALPHA2-a domain and zincx-ray diffractionC, F, I, L, O, RSO4, ZN, NA, CL—
P17301AlphaFold monomer V2.0 prediction for integrin alpha-2 (P17301)predictedA——

Ligands

  • CL · Chloride ion · in 15 records
  • SO4 · Sulfate ion · in 15 records
  • NA · Sodium ion · in 14 records
  • CA · Calcium ion · in 3 records
  • BA · Barium ion · in 2 records
  • ZN · Zinc ion · in 2 records
  • CD · Cadmium ion · in 1 record
  • CO · Cobalt (II) ion · in 1 record
  • CR · Chromium ion · in 1 record
  • MG · Magnesium ion · in 1 record
  • MN · Manganese (II) ion · in 1 record
  • PR · Praseodymium ion · in 1 record
  • SR · Strontium ion · in 1 record
  • Y1 · Yttrium ion · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.